Treatment | n |
Surgery | 21 (20.2%) |
Active surveillance | 20 (19.2%) |
Long-acting SSA | 13 (12.5%) |
None | 12 (11.5%) |
CMT | 11 (10.6%) |
Surgery, CMT | 10 (9.6%) |
Further diagnostic procedure | 5 (4.8%) |
Surgery, interferon | 4 (3.8%) |
Surgery, 90Y, SSA | 4 (3.8%) |
PRRT | 1 (1.0%) |
Surgery, CMT, SSA, TACE, LDT | 1 (1.0%) |
Surgery, radiofrequency ablation | 1 (1.0%) |
LDT | 1 (1.0%) |
SSA = somatostatin analogs; CMT = chemotherapy; 90Y = 90Y-DOTATATE therapy; TACE = transcatheter arterial chemoembolization; LDT = liver-directed therapy.